184 related articles for article (PubMed ID: 23562272)
1. Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholine receptor-redirected T cells.
Simon-Keller K; Paschen A; Hombach AA; Ströbel P; Coindre JM; Eichmüller SB; Vincent A; Gattenlöhner S; Hoppe F; Leuschner I; Stegmaier S; Koscielniak E; Leverkus M; Altieri DC; Abken H; Marx A
Am J Pathol; 2013 Jun; 182(6):2121-31. PubMed ID: 23562272
[TBL] [Abstract][Full Text] [Related]
2. [Adoptive T-cell therapy of rhabdomyosarcoma].
Simon-Keller K; Paschen A; Eichmüller S; Gattenlöhner S; Barth S; Koscielniak E; Leuschner I; Stöbel P; Hombach A; Abken H; Marx A
Pathologe; 2010 Oct; 31 Suppl 2():215-20. PubMed ID: 20730458
[TBL] [Abstract][Full Text] [Related]
3. [Rhabdomyosarcoma lysis by T cells expressing a human autoantibody based chimeric receptor targeting the fetal acetylcholine receptors].
Gattenlöhner S
Verh Dtsch Ges Pathol; 2006; 90():264-76. PubMed ID: 17867605
[TBL] [Abstract][Full Text] [Related]
4. Comparable in vivo efficacy of CD28/B7, ICOS/GL50, and ICOS/GL50B costimulatory pathways in murine tumor models: IFNgamma-dependent enhancement of CTL priming, effector functions, and tumor specific memory CTL.
Zuberek K; Ling V; Wu P; Ma HL; Leonard JP; Collins M; Dunussi-Joannopoulos K
Cell Immunol; 2003 Sep; 225(1):53-63. PubMed ID: 14643304
[TBL] [Abstract][Full Text] [Related]
5. Rejection of syngeneic colon carcinoma by CTLs expressing single-chain antibody receptors codelivering CD28 costimulation.
Haynes NM; Trapani JA; Teng MW; Jackson JT; Cerruti L; Jane SM; Kershaw MH; Smyth MJ; Darcy PK
J Immunol; 2002 Nov; 169(10):5780-6. PubMed ID: 12421958
[TBL] [Abstract][Full Text] [Related]
6. CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models.
Timpanaro A; Piccand C; Dzhumashev D; Anton-Joseph S; Robbi A; Moser J; Rössler J; Bernasconi M
J Exp Clin Cancer Res; 2023 Nov; 42(1):293. PubMed ID: 37924157
[TBL] [Abstract][Full Text] [Related]
7. Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.
Kanwar JR; Shen WP; Kanwar RK; Berg RW; Krissansen GW
J Natl Cancer Inst; 2001 Oct; 93(20):1541-52. PubMed ID: 11604477
[TBL] [Abstract][Full Text] [Related]
8. Enhanced effector and memory CTL responses generated by incorporation of receptor activator of NF-kappa B (RANK)/RANK ligand costimulatory molecules into dendritic cell immunogens expressing a human tumor-specific antigen.
Wiethe C; Dittmar K; Doan T; Lindenmaier W; Tindle R
J Immunol; 2003 Oct; 171(8):4121-30. PubMed ID: 14530334
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules.
Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M
J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480
[TBL] [Abstract][Full Text] [Related]
10. Targeting T cell costimulation in autoimmune disease.
Stuart RW; Racke MK
Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069
[TBL] [Abstract][Full Text] [Related]
11. Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells.
Ogasawara K; Yoshinaga SK; Lanier LL
J Immunol; 2002 Oct; 169(7):3676-85. PubMed ID: 12244160
[TBL] [Abstract][Full Text] [Related]
12. CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.
Azuma M; Cayabyab M; Buck D; Phillips JH; Lanier LL
J Exp Med; 1992 Feb; 175(2):353-60. PubMed ID: 1370679
[TBL] [Abstract][Full Text] [Related]
13. IGF2BP1 controls cell death and drug resistance in rhabdomyosarcomas by regulating translation of cIAP1.
Faye MD; Beug ST; Graber TE; Earl N; Xiang X; Wild B; Langlois S; Michaud J; Cowan KN; Korneluk RG; Holcik M
Oncogene; 2015 Mar; 34(12):1532-41. PubMed ID: 24704827
[TBL] [Abstract][Full Text] [Related]
14. Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model.
Dobson CC; Naing T; Beug ST; Faye MD; Chabot J; St-Jean M; Walker DE; LaCasse EC; Stojdl DF; Korneluk RG; Holcik M
Oncotarget; 2017 Jan; 8(2):3495-3508. PubMed ID: 27966453
[TBL] [Abstract][Full Text] [Related]
15. Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
Chacon JA; Wu RC; Sukhumalchandra P; Molldrem JJ; Sarnaik A; Pilon-Thomas S; Weber J; Hwu P; Radvanyi L
PLoS One; 2013; 8(4):e60031. PubMed ID: 23560068
[TBL] [Abstract][Full Text] [Related]
16. Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.
Schmidt SM; Schag K; Müller MR; Weck MM; Appel S; Kanz L; Grünebach F; Brossart P
Blood; 2003 Jul; 102(2):571-6. PubMed ID: 12576330
[TBL] [Abstract][Full Text] [Related]
17. Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.
Vingerhoets JH; Vanham GL; Kestens LL; Penne GG; Colebunders RL; Vandenbruaene MJ; Goeman J; Gigase PL; De Boer M; Ceuppens JL
Clin Exp Immunol; 1995 Jun; 100(3):425-33. PubMed ID: 7539725
[TBL] [Abstract][Full Text] [Related]
18. Targeting the fetal acetylcholine receptor in rhabdomyosarcoma.
Simon-Keller K; Barth S; Vincent A; Marx A
Expert Opin Ther Targets; 2013 Feb; 17(2):127-38. PubMed ID: 23231343
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
20. Induction of autologous tumor-specific cytotoxic T-lymphocyte activity against a human renal carcinoma cell line by B7-1 (CD8O) costimulation.
Wang YC; Zhu L; McHugh R; Graham SD; Hillyer CD; Dillehay D; Sell KW; Selvaraj P
J Immunother Emphasis Tumor Immunol; 1996 Jan; 19(1):1-8. PubMed ID: 9147700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
